These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3498438)

  • 1. In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.
    Arlet G; Sanson-Le Pors MJ; Casin IM; Ortenberg M; Perol Y
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1283-4. PubMed ID: 3498438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.
    Rummens JL; Gordts B; Van Landuyt HW
    Antimicrob Agents Chemother; 1986 Nov; 30(5):739-42. PubMed ID: 3800350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.
    Roscoe DL; Zemcov SJ; Thornber D; Wise R; Clarke AM
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2197-200. PubMed ID: 1444299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.
    Sutter VL; Pyeatt D; Kwok YY
    Antimicrob Agents Chemother; 1981 Aug; 20(2):270-1. PubMed ID: 7283424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.
    Jolivet-Gougeon A; Buffet A; Dupuy C; Sixou JL; Bonnaure-Mallet M; David S; Cormier M
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3186-8. PubMed ID: 11036049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.
    Lachance N; Gaudreau C; Lamothe F; Turgeon F
    Antimicrob Agents Chemother; 1993 May; 37(5):1174-6. PubMed ID: 8390812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents.
    Lachance N; Gaudreau C; Lamothe F; Larivière LA
    Antimicrob Agents Chemother; 1991 May; 35(5):813-8. PubMed ID: 1854162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Capnocytophaga species to antimicrobial agents.
    Hawkey PM; Smith SD; Haynes J; Malnick H; Forlenza SW
    Antimicrob Agents Chemother; 1987 Feb; 31(2):331-2. PubMed ID: 3566254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-lactamase of Staphylococcus intermedius on disk agar diffusion susceptibility tests.
    Roy AF; Newman SS; Cox HU; Hoskins JD
    Cornell Vet; 1984 Oct; 74(4):354-60. PubMed ID: 6332707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.
    Lacroix JM; Lamothe F; Malouin F
    Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cfxA expression in oral clinical Capnocytophaga isolates.
    Tamanai-Shacoori Z; Monfort C; Oliviero N; Gautier P; Bonnaure-Mallet M; Jolivet-Gougeon A
    Anaerobe; 2015 Oct; 35(Pt B):68-71. PubMed ID: 26204794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.
    Jacobs MR; Spangler SK; Appelbaum PC
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1081-93. PubMed ID: 1295763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria.
    Bremmelgaard A; Pers C; Kristiansen JE; Korner B; Heltberg O; Frederiksen W
    APMIS; 1989 Jan; 97(1):43-8. PubMed ID: 2914105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
    Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
    Appelbaum PC; Spangler SK; Jacobs MR
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.
    Rosenau A; Cattier B; Gousset N; Harriau P; Philippon A; Quentin R
    Antimicrob Agents Chemother; 2000 Mar; 44(3):760-2. PubMed ID: 10681352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Capnocytophaga.
    Forlenza SW; Newman MG; Horikoshi AL; Blachman U
    Antimicrob Agents Chemother; 1981 Jan; 19(1):144-6. PubMed ID: 7247353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.